|The CEACAM6 cea (Catalog #MBS310971) is an Antibody produced from Host: Mouse. Hybridization of P3X63-Ag8.653 myeloma cells with spleen cells from Balb/c mice.
Source: Ascites and is intended for research purposes only. The product is available for immediate purchase.
For enzyme conjugation, radio-labeling or solid phase immobilization. Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be. Researchers should empirically determine the suitability of the CEACAM6 cea for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The CEACAM6 cea product has the following accession number(s) (GI #553222) (NCBI Accession #AAA51971.1) (Uniprot Accession #Q13985). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: Purified CEA from pooled tumors
Affinity Constant: 2 x 10^9. Buffer: 0.015M Potassium Phosphate buffer, 0.15M Sodium Chloride, pH 7.2.
Preservative: 0.1% Sodium Azide
Warnings: This product contains sodium azide, which has been classified as Xn (Harmful), in European Directive 67/548/EEC in the concentration range of 0.1 - 1.0 %. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CEACAM6 are readily searchable from our website. Different antibodies against the same target such as CEACAM6 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. CEACAM6 also interacts with the following gene(s): CEACAM1, CEACAM8. Adenocarcinoma, Breast Neoplasms, Inflammation, Leukemia, Myeloid, Acute, Lung Neoplasms, Lymphoma, Necrosis, Neoplasms, Neoplasms, Experimental, Stomach Neoplasms are some of the diseases may be linked to MAb to Carcinoembryonic Ag. Bladder, Blood, Intestine, Kidney, Lung, Muscle, Pancreas, Prostate, Skin, Stomach tissues are correlated with this protein.